Abbott Vascular International BVBA
About Abbott Vascular International BVBA
"Abbott richt zich met haar producten op het gebied van diagnostiek, medische hulpmiddelen, voeding en farmaceutische producten op de zorgbehoeften van mensen in meer dan 150 landen. Onze diversiteit – qua expertise, technologie en geografie – geeft ons de mogelijkheid om structureel iets te kunnen betekenen voor miljoenen mensen in uiteenlopende regio's en met uiteenlopende culturen."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Abbott Vascular International BVBA
During the past decade, Abbott Vascular International BVBA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
2004-09-01
2008-07-01
Unknown status
400
Rosuvastatin Prevent Contrast Induced Acute Kidney Injury in Patients With Diabetes
2008-12-01
2011-11-01
Completed
2,998
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
2002-06-01
2006-02-01
Completed
274
12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
2002-06-01
2006-02-01
Completed
129
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
2009-04-01
2013-05-01
Completed
360
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys
2009-04-11
2014-11-18
Completed
1,842
Efficacy and Safety of Ypeginterferon Alfa-2b in Chronic Hepatitis C
2010-07-01
2012-03-01
Completed
211
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Abbott Vascular International BVBA
According to Clinical.Site data, the most researched conditions in "Abbott Vascular International BVBA" are
"Coronary Artery Disease" (2 trials), "Atherosclerosis" (1 trials), "Chronic Total Occlusion of Coronary Artery" (1 trials), "Claudication" (1 trials) and "Coronary Artery Restenosis" (1 trials). Many other conditions were trialed in "Abbott Vascular International BVBA" in a lesser frequency.
Clinical Trials Intervention Types at Abbott Vascular International BVBA
Most popular intervention types in "Abbott Vascular International BVBA" are "Device" (3 trials). Other intervention types were less common.
The name of intervention was led by "Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold System" (1 trials), "Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System" (1 trials), "Absorb Bioresorbable Vascular Scaffold" (1 trials) and "ESPRIT BVS" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Abbott Vascular International BVBA
The vast majority of trials in "Abbott Vascular International BVBA" are
3 trials for "All" genders.
Clinical Trials Status at Abbott Vascular International BVBA
Currently, there are NaN active trials in "Abbott Vascular International BVBA".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Abbott Vascular International BVBA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Abbott Vascular International BVBA, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".